Who Is a Good Candidate for TMS Therapy for Treatment-Resistant Depression in Bend, OR?

Depression affects millions of adults across the United States each year, and for many, standard treatments such as antidepressant medications do not provide adequate relief. Research suggests that roughly one-third of individuals diagnosed with major depressive disorder (MDD) are resistant to medication, and more than half may not respond sufficiently to their first prescribed antidepressant. For those living with treatment-resistant depression (TRD) in Bend, OR, and the surrounding region, a common question arises: what is TMS therapy, and could I be eligible for it? At Path to Awareness, helping patients understand their candidacy for this advanced, FDA-approved treatment is a central part of the care process.

Understanding What Is TMS Therapy

Transcranial Magnetic Stimulation (TMS) is an FDA-approved, non-invasive treatment designed specifically for adults with treatment-resistant depression. Unlike medications that circulate throughout the body, TMS uses focused magnetic pulses to stimulate targeted regions of the brain associated with mood regulation. Because the treatment is non-systemic, it avoids many of the side effects commonly associated with antidepressants, such as weight gain, fatigue, or gastrointestinal discomfort.

TMS does not require anesthesia or sedation, and patients remain fully awake and alert throughout each session. A typical course of treatment involves sessions lasting approximately 20 minutes, administered several times per week over a period of four to six weeks. Many patients are able to resume their normal daily activities immediately following each session, making TMS a practical option for individuals with busy schedules.

For those still asking what is TMS therapy and whether it fits their situation, the answer often depends on a combination of clinical history, current health status, and prior treatment outcomes. Path to Awareness works closely with each patient to evaluate these factors during an initial consultation.

Who Qualifies as a Good Candidate for TMS Therapy?

Not every individual with depression will be an ideal candidate for TMS. The treatment is specifically designed for adults who have been diagnosed with major depressive disorder and have not experienced adequate improvement from other approaches. The following factors are generally considered when determining eligibility:

A Diagnosis of Major Depressive Disorder

TMS therapy is indicated for individuals who carry a formal diagnosis of MDD. This diagnosis is typically made by a psychiatrist, primary care provider, or other qualified mental health professional. Patients seeking TMS at Path to Awareness should have a documented history of depressive episodes consistent with established diagnostic criteria.

Inadequate Response to Antidepressant Medications

One of the primary eligibility criteria for TMS is a history of treatment resistance. In clinical terms, this generally means that a patient has tried at least two different antidepressant medications at adequate doses and durations without achieving sufficient symptom relief. Some patients may have tried several medications or combinations without success. Others may have discontinued medications due to intolerable side effects. In either case, TMS may represent a viable next step.

This is a significant consideration because research indicates that approximately 33% of individuals with MDD are medication-resistant, meaning a substantial number of people living with depression may benefit from exploring alternatives like TMS.

Adults Aged 18 and Older

TMS therapy is generally approved and indicated for use in adults. Patients who are 18 years of age or older and meet the other clinical criteria may be considered eligible candidates. Adolescents and children are typically not evaluated for TMS outside of specialized research settings.

Willingness to Commit to a Full Course of Treatment

Because TMS therapy delivers results over a series of sessions rather than through a single procedure, candidates should be prepared to attend sessions consistently over the treatment period. At Path to Awareness, a standard course of TMS typically involves multiple sessions per week for approximately four to six weeks. Commitment to the full treatment schedule is an important factor in achieving optimal outcomes.

Factors That May Affect Eligibility

While TMS therapy is well-tolerated by many individuals, certain medical conditions or circumstances may affect whether someone is a suitable candidate. It is important to discuss your complete medical history with a qualified provider before beginning treatment.

Metal Implants and Medical Devices

Because TMS uses magnetic pulses, individuals who have metallic implants in or near the head-such as cochlear implants, metal plates, or certain types of stents-may not be eligible. Similarly, patients with implanted devices such as pacemakers or deep brain stimulators should inform their provider, as these devices may interact with the magnetic field. Standard dental fillings and braces are generally not a concern.

History of Seizures

Patients with a personal history of seizures or epilepsy should discuss this with their provider. While the risk of seizure during TMS is considered very low, a history of seizure activity may influence eligibility and requires careful clinical evaluation.

Current Medications and Other Treatments

TMS can often be used alongside existing medications and therapy. However, certain medications that lower the seizure threshold may need to be reviewed before treatment begins. Your provider at Path to Awareness will assess your current medication regimen as part of the eligibility evaluation.

Pregnancy

The safety of TMS during pregnancy has not been extensively studied. Individuals who are pregnant or planning to become pregnant should discuss this with their provider to weigh potential risks and benefits.

What Makes TMS Different from Other Depression Treatments?

Understanding what is TMS therapy in the broader context of depression treatment can help patients appreciate why it may be a good fit for those who have not responded to other interventions. Unlike electroconvulsive therapy (ECT), TMS does not require anesthesia, does not induce seizures, and is not associated with the memory-related side effects that can accompany ECT. Unlike oral medications, TMS delivers targeted stimulation directly to the brain regions involved in mood regulation without producing systemic side effects.

The most commonly reported side effect of TMS is mild scalp discomfort at the treatment site during or shortly after sessions, which typically diminishes over the course of treatment. Many patients find this far more manageable than the side effects associated with antidepressant medications.

Clinical data from 2026 suggests that approximately 50% to 60% of patients with treatment-resistant depression experience meaningful symptom reduction with TMS, and roughly one-third may achieve full remission. Additionally, about 60% of individuals who respond to TMS maintain their improvement at the 12-month mark, suggesting durable benefits for many patients. These outcomes are encouraging, though individual results may vary, and TMS should not be viewed as a guaranteed cure.

How to Determine Your Eligibility at Path to Awareness

If you live in Bend, OR, Medford, OR, or the surrounding areas and have been struggling with depression that has not responded to medication, exploring your eligibility for TMS therapy is a straightforward process. Path to Awareness offers consultations designed to evaluate your clinical history, current symptoms, medication trials, and overall health to determine whether TMS is an appropriate treatment option for you.

During your initial evaluation, a qualified provider will review your diagnosis, discuss previous treatment attempts, and address any medical factors that could influence your candidacy. This personalized assessment ensures that the decision to pursue TMS is informed, safe, and aligned with your individual treatment goals.

It is also worth noting that TMS therapy at Path to Awareness is covered by many major insurance providers, including Aetna, BCBS, Cigna, United Healthcare, Tri-Care, Humana, Medicare, Optum, Medicaid, and the Oregon Health Plan (OHP). This broad coverage may make TMS more accessible for eligible patients in the region.

Taking the Next Step Toward Relief

Living with treatment-resistant depression can feel isolating, especially when the treatments you have tried have not provided the relief you need. Understanding what is TMS therapy and whether you may be a good candidate is an important first step toward exploring new possibilities. TMS has been shown to help many individuals achieve significant improvement in their symptoms, offering a path forward when other options have fallen short.

If you believe you may qualify for TMS therapy, or if you simply have questions about the treatment and your eligibility, Path to Awareness encourages you to reach out and schedule a consultation. Serving patients in Bend and Medford, the team at Path to Awareness is committed to providing thorough, compassionate evaluations to help you make an informed decision about your mental health care. Contact Path to Awareness today to learn more about TMS therapy and take the next step on your journey toward improved well-being.